NYSE:CNC Centene (CNC) Stock Price, News & Analysis $65.18 -1.92 (-2.85%) Closing price 09/18/2026 03:59 PM EasternExtended Trading$65.70 +0.52 (+0.79%) As of 09/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Centene Stock (NYSE:CNC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Centene alerts:Sign Up Key Stats Today's Range$65.03▼$67.7350-Day Range$60.84▼$69.4852-Week Range$31.63▼$69.63Volume13.44 million shsAverage Volume3.98 million shsMarket Capitalization$32.20 billionP/E RatioN/ADividend YieldN/APrice Target$70.05Consensus RatingHold Company Overview Centene Corporation (NYSE: CNC) is a managed-care company that provides health insurance and related healthcare services, primarily through government-sponsored programs. Its offerings include Medicaid, Medicare Advantage and Medicare Prescription Drug plans, coverage for individuals and families through the health insurance marketplace, and health services for military families and veterans. The company markets several healthcare brands, including Ambetter, which provides marketplace plans, and Wellcare, which offers Medicare products. Centene also provides specialized services such as behavioral health, pharmacy benefit management, care management, and services for people with complex or special healthcare needs. Its plans are offered through contracts with state and federal governments and serve members across the United States. Centene was founded in 1984 and is headquartered in St. Louis, Missouri. The company has expanded through organic growth and acquisitions, including the 2016 acquisition of Health Net and the 2021 acquisition of Magellan Health. Sarah M. London serves as Centene’s chief executive officer.AI Generated. May Contain Errors. Read More Centene Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks72nd Percentile Overall ScoreCNC MarketRank™: Centene scored higher than 72% of companies evaluated by MarketBeat, and ranked 185th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingHold Consensus RatingCentene has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 9 buy ratings, 9 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageCentene has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Centene's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.20% Earnings GrowthEarnings for Centene are expected to grow by 9.20% in the coming year, from $4.89 to $5.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Centene is -6.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Centene is -6.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCentene has a PEG Ratio of 0.41. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCentene has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Centene's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.73% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 3.46, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently increased by 1.17%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCentene does not currently pay a dividend.Dividend GrowthCentene does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.77 News SentimentCentene has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Centene this week, compared to 8 articles on an average week.Search InterestOnly 16 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows16 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 7% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Centene insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,891,182.00 in company stock.Percentage Held by Insiders0.37% of the stock of Centene is held by insiders.Percentage Held by Institutions93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Centene's insider trading history. Receive CNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNC Stock News HeadlinesCentene (CNC) Could Be 6% Undervalued Following Renewed Interest In Earnings And ICHRA GrowthSeptember 19 at 2:47 AM | finance.yahoo.comBarclays Sticks to Their Buy Rating for Centene (CNC)September 18 at 4:47 PM | theglobeandmail.comWhat Elon Musk did in June 2024In June 2024, Elon Musk faced a problem every AI company was about to hit — how to power a massive AI computer fast. Just 122 days later, it was running. Meta, OpenAI, and Microsoft followed with multi-decade contracts. Blackstone put in 5.34 billion dollars, and a related income vehicle has paid an average of 7 billion dollars every 90 days.September 20 at 1:00 AM | Behind the Markets (Ad)Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit TranscriptSeptember 16, 2026 | seekingalpha.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)September 16, 2026 | theglobeandmail.comCentene Reaffirms 2026 Adjusted Earnings OutlookSeptember 16, 2026 | finance.yahoo.comCentene (NYSE:CNC) General Counsel Christopher Koster Sells 56,500 SharesAugust 28, 2026 | insidertrades.comCentene (NYSE:CNC) General Counsel Christopher Koster Sells 47,603 SharesAugust 20, 2026 | insidertrades.comSee More Headlines CNC Stock Analysis - Frequently Asked Questions How have CNC shares performed this year? Centene's stock was trading at $41.18 at the beginning of the year. Since then, CNC shares have increased by 58.3% and is now trading at $65.1850. How were Centene's earnings last quarter? Centene Corporation (NYSE:CNC) issued its quarterly earnings data on Monday, July, 27th. The company reported $2.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.09 by $1.42. The business's revenue for the quarter was up 9.9% on a year-over-year basis. Read the conference call transcript. When did Centene's stock split? Centene's stock split on the morning of Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were issued to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does Centene have any subsidiaries? The following companies are subsidiaries of Centene: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others. Who are Centene's major shareholders? Top institutional investors of Centene include BlackRock Inc. (8.39%), Wellington Management Group LLP (2.69%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.12%) and Bank of America Corp DE (0.90%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Christopher Koster, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas. View institutional ownership trends. How do I buy shares of Centene? Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ). Company Calendar Last Earnings7/27/2026Today9/20/2026Next Earnings (Estimated)10/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 CNC's financial health is in the Green zone, according to TradeSmith. CNC has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:CNC CIK1071739 Webwww.centene.com Phone(314) 725-4477Fax314-558-2428Employees61,100Year Founded1984Price Target and Rating Average Price Target for Centene$70.05 High Price Target$80.00 Low Price Target$40.00 Potential Upside/Downside+7.5%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)($10.44) Trailing P/E RatioN/A Forward P/E Ratio13.33 P/E Growth0.41Net Income-$6.67 billion Net Margins-2.51% Pretax Margin-2.28% Return on Equity12.12% Return on Assets3.20% Debt Debt-to-Equity Ratio0.71 Current Ratio1.15 Quick Ratio1.15 Sales & Book Value Annual Sales$194.78 billion Price / Sales0.17 Cash Flow$4.69 per share Price / Cash Flow13.90 Book Value$40.76 per share Price / Book1.60Miscellaneous Outstanding Shares493,990,000Free Float492,167,000Market Cap$32.20 billion OptionableOptionable Beta1.10 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:CNC) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredWhat Elon Musk did in June 2024In June 2024, Elon Musk faced a problem every AI company was about to hit — how to power a massive AI computer...Behind the Markets | SponsoredIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | SponsoredWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technolog...Stansberry Research | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
